Literature DB >> 12764382

Lack of telomerase activity in human mesenchymal stem cells.

S Zimmermann1, M Voss, S Kaiser, U Kapp, C F Waller, U M Martens.   

Abstract

Telomerase activity and telomere maintenance have been associated with immortality in tumor and embryonic stem cells. Whereas most normal somatic cells are telomerase negative, low levels of this enzyme have been found in adult stem cells from the skin, gut and the hematopoietic system. Here, we show that telomerase activity is not detectable in human mesenchymal stem cells (hMSCs), which have the phenotype SH2+, SH3+, SH4+, CD29+, CD44+, CD14-, CD34- and CD45-, and have the capacity to differentiate into adipocytes, chondrocytes and osteoblasts. These data suggest that hMSCs have a different telomere biology compared to other adult stem cells. Alternatively, true mesenchymal stem cells might be a very rare subpopulation that have a detection level that is below the sensitivity of the TRAP assay.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12764382     DOI: 10.1038/sj.leu.2402962

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  74 in total

1.  Changes of the Functional Capacity of Mesenchymal Stem Cells due to Aging or Age-Associated Disease - Implications for Clinical Applications and Donor Recruitment.

Authors:  Günter Lepperdinger; Regina Brunauer; Robert Gassner; Angelika Jamnig; Frank Kloss; Gerhard Thomas Laschober
Journal:  Transfus Med Hemother       Date:  2008-07-17       Impact factor: 3.747

2.  Defining essential stem cell characteristics in adipose-derived stromal cells extracted from distinct anatomical sites.

Authors:  Patrick C Sachs; Michael P Francis; Min Zhao; Jenni Brumelle; Raj R Rao; Lynne W Elmore; Shawn E Holt
Journal:  Cell Tissue Res       Date:  2012-05-25       Impact factor: 5.249

Review 3.  Regenerative therapy after cancer: what are the risks?

Authors:  Vera S Donnenberg; Ludovic Zimmerlin; Joseph Peter Rubin; Albert D Donnenberg
Journal:  Tissue Eng Part B Rev       Date:  2010-11-02       Impact factor: 6.389

Review 4.  Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases.

Authors:  Jakob Reiser; Xian-Yang Zhang; Charles S Hemenway; Debasis Mondal; Leena Pradhan; Vincent F La Russa
Journal:  Expert Opin Biol Ther       Date:  2005-12       Impact factor: 4.388

Review 5.  Mesenchymal stem cells: lineage, plasticity, and skeletal therapeutic potential.

Authors:  Richard O C Oreffo; Cyrus Cooper; Christopher Mason; Mark Clements
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

Review 6.  Corneal epithelial stem cells in health and disease.

Authors:  Julie T Daniels; Anna R Harris; Chris Mason
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 7.  Stem cell function and maintenance - ends that matter: role of telomeres and telomerase.

Authors:  Hamid Saeed; Mehwish Iqtedar
Journal:  J Biosci       Date:  2013-09       Impact factor: 1.826

8.  Immune regulatory properties of multipotent mesenchymal stromal cells: Where do we stand?

Authors:  Enio José Bassi; Carlos Alberto Mayora Aita; Niels Olsen Saraiva Câmara
Journal:  World J Stem Cells       Date:  2011-01-26       Impact factor: 5.326

Review 9.  Biological functions of mesenchymal stem cells and clinical implications.

Authors:  Abderrahim Naji; Masamitsu Eitoku; Benoit Favier; Frédéric Deschaseaux; Nathalie Rouas-Freiss; Narufumi Suganuma
Journal:  Cell Mol Life Sci       Date:  2019-05-04       Impact factor: 9.261

10.  A gene expression signature classifying telomerase and ALT immortalization reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT.

Authors:  K Lafferty-Whyte; C J Cairney; M B Will; N Serakinci; M-G Daidone; N Zaffaroni; A Bilsland; W N Keith
Journal:  Oncogene       Date:  2009-08-17       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.